Rose Geoffrey Beran's Form 4 filing
Pulmonx Corp (LUNG) · filed Mar 5, 2025
- Accession no.
- 0001415889-25-007034
- Filed
- Mar 5, 2025
- Trade date
- Mar 3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $41.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rose Geoffrey BeranCIK 0001804146 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | SSaleDisposed | −520 | $7.12 | −$3,702.4 | 290,537 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −915 | $7.12 | −$6,514.8 | 289,622 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −2,327 | $7.14 | −$16,614.78 | 287,295 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −2,017 | $7.12 | −$14,361.04 | 285,278 | Direct | |
| Mar 3, 2025 | Common Stock | AGrant or awardAcquired | +108,000 | $0.00 | $0 | 393,278 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.